Abstract #0920
Quantitative DCE-MRI Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy
Alina Tudorica 1 , Karen Y Oh 1 , Stephen Y-C Chui 1 , Nicole Roy 1 , Megan L Troxell 1 , Yiyi Chen 1 , Arpana Naik 1 , Megan L Holtorf 1 , Aneela Afzal 1 , Zunqiu Chen 1 , Charles S Springer 1 , Xin Li 1 , and Wei Huang 1
1
Oregon Health & Science University,
Portland, Oregon, United States
Fifteen women with breast cancer underwent DCE-MRI
before, during, and after neoadjuvant chemotherapy.
Pharmacokinetic analysis of DCE-MRI data were performed
using Standard (Tofts) model (SM) and Shutter-Speed
model (SSM). After only one cycle of therapy, % changes
in SM and SSM Ktrans and kep, and SSM-unique Tau_i, as
well as absolute values of Ktrans and kep, provieded
excellent early predictions of pathologic complete
response. Following therapy completion, tumor Tau_i was
inversely, while Ktrans and tumor size were positively,
correlated with residual disease burden. In conclusion,
DCE-MRI functional parameters provided earlier
prediction of response and more accurate assessment of
residual disease compared to tumor size measurement.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
